Sorrento Therapeutics Inc (SRNE)

[Maple tree]

Here is some of information.

"which was awarded $92 million with the potential for the contract to go up to $211 million, as it works on various initiatives for treating the virus. That includes a program with Sanofi evaluating Kevzara, a drug typically used by those suffering from rheumatoid arthritis, as a treatment, as well as the development of “a novel multi-antibody cocktail” that could go into clinical studies by summer."